GSK pioneer a single-step cloning strategy to generate novel recombinant sub unit vaccine candidates.
Currently we are living in unprecedented times with a global health threat from a novel respiratory disease that has spread within weeks. We are trying to subvert a large percentage of the population succumbing to this virus through early detection and isolation strategy. There is the potential need for a long-term treatment if variants of …